Home
Strides Pharma Science Ltd 52 Week High

Strides Pharma Science Ltd
NSE: STAR
YEARHIGH
Key Highlights
- The 52 Week HIGH of Strides Pharma Science Ltd is ₹ 785.85 as of 17 Apr 25 .
Company Fundamentals for Strides Pharma Science Ltd
Market Price of Strides Pharma Science Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
17 Apr 2025 | 652.75 |
16 Apr 2025 | 666.3 |
15 Apr 2025 | 619.05 |
11 Apr 2025 | 615.1 |
09 Apr 2025 | 584.05 |
08 Apr 2025 | 593.95 |
07 Apr 2025 | 577.4 |
04 Apr 2025 | 622.65 |
03 Apr 2025 | 699.55 |
02 Apr 2025 | 669.65 |
Asset Value vs Market Value of Strides Pharma Science Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Strides Pharma Science Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Strides Pharma Science Ltd
Historical Net Profit of Strides Pharma Science Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Strides Pharma Science Ltd
Strides Pharma Science Ltd News Hub
Strides Alathur successfully concludes USFDA inspection
Strides Alathur, a wholly owned subsidiary of Strides Pharma Science (Strides) has received an Estab
Read more
19 Aug 24
Strides Pharma arm gets EIR from USFDA for Chennai facility
The good manufacturing practices (GMP) inspection was conducted from 1 April to 5 April 2024. The US
Read more
19 Aug 24
Strides Pharma hits 52-week high after dissolution of US unit
Strides Pharma, as a part of Group entites optimization exercises has liquidated its US unit by the
Read more
16 Aug 24
Strides Pharma Science to hold EGM
Strides Pharma Science announced that an Extra Ordinary General Meeting (EGM) of the Company will be
Read more
09 Aug 24